MA Private Wealth increased its position in Varian Medical Systems, Inc. (NYSE:VAR) by 49.9% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 2,945 shares of the medical equipment provider’s stock after buying an additional 981 shares during the period. MA Private Wealth’s holdings in Varian Medical Systems were worth $351,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of the stock. Morgan Stanley lifted its stake in Varian Medical Systems by 7.4% in the 2nd quarter. Morgan Stanley now owns 274,048 shares of the medical equipment provider’s stock worth $37,307,000 after purchasing an additional 18,955 shares in the last quarter. TD Asset Management Inc. lifted its stake in Varian Medical Systems by 150.7% in the 2nd quarter. TD Asset Management Inc. now owns 190,218 shares of the medical equipment provider’s stock worth $25,894,000 after purchasing an additional 114,352 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. lifted its stake in Varian Medical Systems by 25.3% in the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 7,015 shares of the medical equipment provider’s stock worth $955,000 after purchasing an additional 1,418 shares in the last quarter. BTIM Corp. lifted its stake in Varian Medical Systems by 1.2% in the 2nd quarter. BTIM Corp. now owns 213,262 shares of the medical equipment provider’s stock worth $29,031,000 after purchasing an additional 2,570 shares in the last quarter. Finally, State of Alaska Department of Revenue lifted its stake in Varian Medical Systems by 54.1% in the 3rd quarter. State of Alaska Department of Revenue now owns 40,305 shares of the medical equipment provider’s stock worth $4,798,000 after purchasing an additional 14,143 shares in the last quarter. 91.22% of the stock is owned by institutional investors.

Varian Medical Systems stock traded down $0.45 during midday trading on Thursday, reaching $109.47. The stock had a trading volume of 15,394 shares, compared to its average volume of 756,793. Varian Medical Systems, Inc. has a 52-week low of $101.42 and a 52-week high of $142.50. The firm has a market cap of $10.23 billion, a price-to-earnings ratio of 24.70, a price-to-earnings-growth ratio of 2.69 and a beta of 0.87. The company has a fifty day moving average of $112.12 and a 200 day moving average of $126.27.

Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings data on Wednesday, July 24th. The medical equipment provider reported $1.32 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.14 by $0.18. Varian Medical Systems had a net margin of 10.75% and a return on equity of 24.91%. The company had revenue of $825.80 million for the quarter, compared to analyst estimates of $762.29 million. During the same period in the prior year, the company posted $1.04 EPS. The firm’s revenue for the quarter was up 16.5% on a year-over-year basis. On average, equities analysts forecast that Varian Medical Systems, Inc. will post 4.63 EPS for the current fiscal year.

Several brokerages have commented on VAR. Zacks Investment Research cut shares of Varian Medical Systems from a “strong-buy” rating to a “hold” rating and set a $139.00 price target on the stock. in a research note on Saturday, July 27th. Robert W. Baird set a $158.00 target price on shares of Varian Medical Systems and gave the company a “buy” rating in a research report on Friday, July 26th. TheStreet cut shares of Varian Medical Systems from a “b” rating to a “c+” rating in a research report on Monday, August 5th. Barrington Research upped their target price on shares of Varian Medical Systems from $142.00 to $146.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. Finally, BTIG Research restated a “hold” rating on shares of Varian Medical Systems in a research report on Wednesday, July 24th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $141.67.

In other Varian Medical Systems news, SVP John W. Kuo sold 465 shares of the company’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $110.49, for a total value of $51,377.85. Following the transaction, the senior vice president now directly owns 35,566 shares in the company, valued at approximately $3,929,687.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Timothy E. Guertin sold 12,651 shares of the company’s stock in a transaction dated Monday, July 15th. The stock was sold at an average price of $135.21, for a total transaction of $1,710,541.71. Following the completion of the transaction, the director now owns 13,589 shares in the company, valued at $1,837,368.69. The disclosure for this sale can be found here. Insiders sold a total of 14,046 shares of company stock worth $1,878,876 over the last three months. 0.78% of the stock is currently owned by corporate insiders.

Varian Medical Systems Profile

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment.

See Also: How to interpret a stock’s beta number

Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems, Inc. (NYSE:VAR).

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.